Showing results (1221-1230 of 1,326) with videos related to
Sort By:
Pageof 133
Journal of Affective Disorders|September 19, 2024
Electroencephalography (EEG) spectral signatures of selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake inhibitors (SNRIs) and vortioxetine in major depressive disorder: A systematic reviewGia Han Le, Sabrina Wong, Andy Lu, et al.Journal of Affective Disorders|June 20, 2024
Comparing suicide completion rates in bipolar I versus bipolar II disorder: A systematic review and meta-analysisDonovan A Dev, Gia Han Le, Angela T H Kwan, et al.Bipolar Disorders|December 29, 2022
Proof-of-concept randomized controlled trial of single-session nitrous oxide treatment for refractory bipolar depression: Focus on cerebrovascular target engagementWilliam S H Kim, Mikaela K Dimick, Danielle Omrin, et al.Psychopharmacology|January 23, 2021
Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatmentJason Ng, Leanna M W Lui, Joshua D Rosenblat, et al.Bipolar Disorders|December 17, 2013
Advancing biomarker research: utilizing 'Big Data' approaches for the characterization and prevention of bipolar disorderRoger S McIntyre, Danielle S Cha, Jeanette M Jerrell, et al.Journal of Psychopharmacology (Oxford, England)|September 19, 2013
Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: Possible involvement of antioxidant and nitrergic pathwaysAline Santos Monte, Greicy Coelho de Souza, Roger S McIntyre, et al.Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|January 27, 2018
Determinants of cognitive function in individuals with type 2 diabetes mellitus: A meta-analysisRodrigo B Mansur, Yena Lee, Aileen J Zhou, et al.CNS Spectrums|October 21, 2022
The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophreniaMuhammad Youshay Jawad, Shakila Meshkat, Aniqa Tabassum, et al.Journal of Affective Disorders|July 16, 2020
The utility of smartphone-based, ecological momentary assessment for depressive symptomsSamantha J Yim, Leanna M W Lui, Yena Lee, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 8, 2020
Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of ExcellenceOrly Lipsitz, Roger S McIntyre, Nelson B Rodrigues, et al.Pageof 133